carcrash2d| Hengrui Pharmaceutical (600276.SH): Clinical trial applications for three drugs of subsidiaries have been approved
Zhitong Finance APP Newscarcrash2d, Hengrui Pharmaceutical (600276carcrash2d.SH) issued an announcement that the company's subsidiaries Shanghai Hengr...